AR061619A1 - Inhibidores de proteasa de hiv de 2-(amino-sustituido)- benzotiazol sulfonamida - Google Patents

Inhibidores de proteasa de hiv de 2-(amino-sustituido)- benzotiazol sulfonamida

Info

Publication number
AR061619A1
AR061619A1 ARP070102776A ARP070102776A AR061619A1 AR 061619 A1 AR061619 A1 AR 061619A1 AR P070102776 A ARP070102776 A AR P070102776A AR P070102776 A ARP070102776 A AR P070102776A AR 061619 A1 AR061619 A1 AR 061619A1
Authority
AR
Argentina
Prior art keywords
alkyl
ring members
substituted
amino
optionally
Prior art date
Application number
ARP070102776A
Other languages
English (en)
Spanish (es)
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AR061619A1 publication Critical patent/AR061619A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ARP070102776A 2006-06-23 2007-06-22 Inhibidores de proteasa de hiv de 2-(amino-sustituido)- benzotiazol sulfonamida AR061619A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06116003 2006-06-23

Publications (1)

Publication Number Publication Date
AR061619A1 true AR061619A1 (es) 2008-09-10

Family

ID=37596252

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102776A AR061619A1 (es) 2006-06-23 2007-06-22 Inhibidores de proteasa de hiv de 2-(amino-sustituido)- benzotiazol sulfonamida

Country Status (30)

Country Link
US (1) US8202887B2 (OSRAM)
EP (1) EP2035432B1 (OSRAM)
JP (1) JP5232776B2 (OSRAM)
KR (1) KR101419320B1 (OSRAM)
CN (1) CN101479275B (OSRAM)
AP (1) AP2069A (OSRAM)
AR (1) AR061619A1 (OSRAM)
AT (1) ATE544769T1 (OSRAM)
AU (1) AU2007262943B2 (OSRAM)
BR (1) BRPI0713487B1 (OSRAM)
CA (1) CA2653233C (OSRAM)
CL (1) CL2007001826A1 (OSRAM)
CY (1) CY1112971T1 (OSRAM)
DK (1) DK2035432T3 (OSRAM)
EA (1) EA016387B1 (OSRAM)
ES (1) ES2381129T3 (OSRAM)
IL (1) IL195381A (OSRAM)
JO (1) JO2841B1 (OSRAM)
MX (1) MX2009000160A (OSRAM)
MY (1) MY146805A (OSRAM)
NZ (1) NZ573286A (OSRAM)
PE (1) PE20080342A1 (OSRAM)
PL (1) PL2035432T3 (OSRAM)
PT (1) PT2035432E (OSRAM)
SI (1) SI2035432T1 (OSRAM)
TW (1) TWI415851B (OSRAM)
UA (1) UA96445C2 (OSRAM)
UY (1) UY30416A1 (OSRAM)
WO (1) WO2007147884A1 (OSRAM)
ZA (1) ZA200810350B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3090B1 (ar) 2009-12-11 2017-03-15 Janssen Sciences Ireland Uc 5- امينو-4- هيدروكسي-بنتويل اميدات
CA2802492C (en) 2010-07-02 2018-10-16 Gilead Sciences, Inc. 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds
ES2634490T3 (es) 2010-07-02 2017-09-28 Gilead Sciences, Inc. Derivados de ácido napht-2-ylacetico para tratar el sida
US9024038B2 (en) 2010-12-27 2015-05-05 Purdue Research Foundation Compunds and methods for treating HIV
AP2013007249A0 (en) 2011-04-21 2013-11-30 Gilead Sciences Inc Benzothiazole compounds and their pharmaceutical use
WO2013103724A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
WO2013103738A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. Napthalene acetic acid derivatives against hiv infection
PH12014500842A1 (en) 2012-04-20 2014-06-09 Gilead Sciences Inc Benzothiazol-6-yl acetic acid derivatives and their use for treating an hiv infection
WO2021209563A1 (en) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
US12083099B2 (en) 2020-10-28 2024-09-10 Accencio LLC Methods of treating symptoms of coronavirus infection with viral protease inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ527391A (en) * 2001-02-14 2005-04-29 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
AR037797A1 (es) * 2001-12-12 2004-12-01 Tibotec Pharm Ltd Combinacion de inhibidores de proteasa dependientes del citocromo p450
NZ538488A (en) * 2002-08-02 2007-10-26 Tibotec Pharm Ltd Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
US20080234288A1 (en) * 2003-09-30 2008-09-25 Kenneth Alan Simmen Hcv Inhibiting Sulfonamides

Also Published As

Publication number Publication date
KR20090024257A (ko) 2009-03-06
PE20080342A1 (es) 2008-04-25
BRPI0713487A2 (OSRAM) 2012-11-13
EA016387B1 (ru) 2012-04-30
WO2007147884A1 (en) 2007-12-27
US20090209583A1 (en) 2009-08-20
PT2035432E (pt) 2012-04-24
NZ573286A (en) 2011-09-30
JO2841B1 (en) 2014-09-15
CA2653233C (en) 2015-09-29
CN101479275A (zh) 2009-07-08
KR101419320B1 (ko) 2014-07-14
BRPI0713487B1 (pt) 2022-07-26
MX2009000160A (es) 2009-01-23
BRPI0713487A8 (pt) 2018-01-02
EP2035432A1 (en) 2009-03-18
UA96445C2 (ru) 2011-11-10
CA2653233A1 (en) 2007-12-27
UY30416A1 (es) 2008-01-31
IL195381A0 (en) 2009-08-03
JP5232776B2 (ja) 2013-07-10
TW200817416A (en) 2008-04-16
IL195381A (en) 2013-01-31
EP2035432B1 (en) 2012-02-08
ES2381129T3 (es) 2012-05-23
AP2008004679A0 (en) 2008-12-31
MY146805A (en) 2012-09-28
US8202887B2 (en) 2012-06-19
ZA200810350B (en) 2010-05-26
AU2007262943A1 (en) 2007-12-27
ATE544769T1 (de) 2012-02-15
PL2035432T3 (pl) 2012-07-31
TWI415851B (zh) 2013-11-21
CL2007001826A1 (es) 2008-01-18
AU2007262943B2 (en) 2012-04-12
JP2009541272A (ja) 2009-11-26
HK1125633A1 (en) 2009-08-14
EA200970052A1 (ru) 2009-04-28
DK2035432T3 (da) 2012-05-14
SI2035432T1 (sl) 2012-06-29
CY1112971T1 (el) 2016-04-13
CN101479275B (zh) 2012-03-07
AP2069A (en) 2009-12-08

Similar Documents

Publication Publication Date Title
AR061619A1 (es) Inhibidores de proteasa de hiv de 2-(amino-sustituido)- benzotiazol sulfonamida
CO6210724A2 (es) Compuesto heterociclico y composicion farmaceutica del mismo
AR073369A1 (es) Derivados de 2-carboxamida-cicloamino-urea como inhibidores de pi-3
ECSP088965A (es) Derivados de 2-tioxantina que actúan como inhibidores de la mpo
NI201400099A (es) Composición para el control de plagas que incluye un derivado de iminopiridina novedoso
CO6230986A2 (es) Compuesto de 4-piridinona y su uso para cancer
AR084588A1 (es) Compuesto heterociclico fusionado y su uso para el control de plagas
ES2722409T3 (es) Moduladores de ROR gamma (RORy)
CO6321230A2 (es) Compuesto espiro, una sal aceptable para uso farmaceutico y un solvato del mismo y composicion farmaceutica que lo contenga
CO5611131A2 (es) Derivados de 5-feniltiazol y su uso como inhibidores de pi3 cinasa
CO6150164A2 (es) Derivados de 2-metilmorfolina pirido-,pirazo-ypirimido-pirimidina como inhibidores de mtor
AR064635A1 (es) Derivados de benzotiazolona
CR11245A (es) Mejoras en compuestos organicos o relacionadas con los mismos
AR050932A1 (es) Amidas biciclicas como inhibidores de cinasa
AR065867A1 (es) Compuestosde isoxazolina y su uso en el control de plagas
AR072166A1 (es) Derivado de piperidina y su uso como inhibidor de renina superior
CO4940477A1 (es) Inhibidores de proteasa
ES2663717T3 (es) Síntesis de derivados de 2-carboxamida-cicloamino-urea
CO2018010787A2 (es) Compuesto de griseofulvina
AR068367A1 (es) Derivados de amidas con actividad fungicida
AR077525A1 (es) 4-aril-butan-1,3-diamidas y composiciones farmaceuticas
AR088816A1 (es) Proceso para preparar derivados de 1-acil-4-fenilsulfonilprolinamida y compuestos intermediarios
CO6321159A2 (es) Compuestos pirazina fusionados utiles para el tratamiento de enfermedades degenerativas e inflamatorias
AR124379A1 (es) N-(2-(4-cianotiazolidin-3-il)-2-oxoetil)-quinolin-4-carboxamidas
AR049770A1 (es) Derivados de piperidina como moduladores de la actividad de quimioquinas

Legal Events

Date Code Title Description
FG Grant, registration